A one-stop-shop for tools and information sources supporting the ongoing efforts to defeat the Covid19 pandemic
The Coronavirus R&D Gateway is a resource for researchers, companies, policymakers and the interested public at large. The R&D Gateway has been created in cooperation with several partner organisations. It constitutes a one-stop-shop for a number of tools and information sources supporting the ongoing efforts to defeat the COVID-19 pandemic.
A World Trade Organisation waiver on intellectual property will not overcome immediate vaccine shortages. Compulsory licensing is a better approach
Member states have until the end of April to fine tune and adapt plans to fit with EU climate goals. But will bids to spend money on roads and gas pipelines support a green recovery?
Latest: European Commission close to advance purchase deal for 300M doses of Sanofi/Glaxo COVID-19 vaccine and says more agreements on the way
Projects should focus on new diagnostic technologies, vaccines and treatments, genomic sequencing, epidemiology and computing oriented research.
No upcoming events
For partnership opportunities, contact [email protected]